Survival and Chemosensitivity in Advanced High Grade Serous Epithelial Ovarian Cancer Patients with and without a BRCA Germline Mutation: More Evidence for Shifting the Paradigm towards Complete Surgical Cytoreduction

Background and Objectives: Approximately 10–15% of high-grade serous ovarian cancer (HGSOC) cases are related to BRCA germline mutations. Better survival rates and increased chemosensitivity are reported in patients with a BRCA 1/2 germline mutation. However, the FIGO stage and histopathological ent...

Descripción completa

Detalles Bibliográficos
Autores principales: De Jong, Diederick, Otify, Mohamed, Chen, Inga, Jackson, David, Jayasinghe, Kelum, Nugent, David, Thangavelu, Amudha, Theophilou, Georgios, Laios, Alexandros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699274/
https://www.ncbi.nlm.nih.gov/pubmed/36363568
http://dx.doi.org/10.3390/medicina58111611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699274/
https://www.ncbi.nlm.nih.gov/pubmed/36363568
http://dx.doi.org/10.3390/medicina58111611

Ejemplares similares